Hinge Health, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Hinge Health, Inc. 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About HNGE
Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. It leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for its clients.
CEODaniel Perez
CEODaniel Perez
Employees—
Employees—
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2014
Founded2014
Employees—
Employees—
HNGE Key Statistics
Market cap3.78B
Market cap3.78B
Price-Earnings ratio-8.75
Price-Earnings ratio-8.75
Dividend yield—
Dividend yield—
Average volume1.26M
Average volume1.26M
High today$49.23
High today$49.23
Low today$47.95
Low today$47.95
Open price$48.75
Open price$48.75
Volume911.95K
Volume911.95K
52 Week high$62.18
52 Week high$62.18
52 Week low$32.00
52 Week low$32.00
Stock Snapshot
As of today, Hinge Health, Inc.(HNGE) shares are valued at $48.05. The company's market cap stands at 3.78B, with a P/E ratio of -8.75.
As of 2025-12-18, Hinge Health, Inc.(HNGE) stock has fluctuated between $47.95 and $49.23. The current price stands at $48.05, placing the stock +0.2% above today's low and -2.4% off the high.
Hinge Health, Inc.(HNGE) shares are trading with a volume of 911.95K, against a daily average of 1.26M.
In the last year, Hinge Health, Inc.(HNGE) shares hit a 52-week high of $62.18 and a 52-week low of $32.00.
In the last year, Hinge Health, Inc.(HNGE) shares hit a 52-week high of $62.18 and a 52-week low of $32.00.
Analyst ratings
93%
of 15 ratingsBuy
93.3%
Hold
6.7%
Sell
0%
People also own
Based on the portfolios of people who own HNGE. This list is generated using Robinhood data, and it’s not a recommendation.